Chronic hepatitis B infection in pregnancy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 28, 2015; 7(9): 1233-1237
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1233

Table 1 Food and Drug Administration pregnancy categories for nucleos(t)ide analogues for hepatitis B

LdT: Telbivudine; TDF: Tenofovir; LAM: Lamivudine.

Citation: Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World J Hepatol 2015; 7(9): 1233-1237
URL: https://www.wjgnet.com/1948-5182/full/v7/i9/1233.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i9.1233

Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World J Hepatol 2015; 7(9): 1233-1237 [PMID: 26019737 DOI: 10.4254/wjh.v7.i9.1233]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.